Heron Therapeutics Inc vs Solaredge Technologies Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Solaredge Technologies Inc trades at $33.89 (market cap $2.05B). The key difference: Solaredge Technologies Inc is far larger — about 33.3× Heron Therapeutics Inc's market cap, and Solaredge Technologies Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | SEDG | |
|---|---|---|
Market Cap | $61.47M | $2.05B |
Sector | Health | Technology |
52-Week High | $1.49 | $78.51 |
52-Week Low | $0.32 | $25.10 |
Enterprise Value | $168.21M | $1.91B |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →